20-2860506-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_022575.4(VPS16):c.427G>A(p.Gly143Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_022575.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VPS16 | NM_022575.4 | c.427G>A | p.Gly143Arg | missense_variant | 5/24 | ENST00000380445.8 | |
VPS16 | NM_080413.3 | c.427G>A | p.Gly143Arg | missense_variant | 5/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VPS16 | ENST00000380445.8 | c.427G>A | p.Gly143Arg | missense_variant | 5/24 | 1 | NM_022575.4 | P1 | |
VPS16 | ENST00000380469.7 | c.427G>A | p.Gly143Arg | missense_variant | 5/20 | 2 | |||
VPS16 | ENST00000453689.5 | c.73G>A | p.Gly25Arg | missense_variant | 3/10 | 3 | |||
VPS16 | ENST00000417508.1 | c.73G>A | p.Gly25Arg | missense_variant | 3/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151992Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251416Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135894
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461820Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 727216
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151992Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74216
ClinVar
Submissions by phenotype
VPS16-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 23, 2024 | The VPS16 c.427G>A variant is predicted to result in the amino acid substitution p.Gly143Arg. To our knowledge, this variant has not been reported in the literature in association with VPS16-related dystonia. This variant was reported with de novo occurrence in an individual with an undefined developmental disorder (Turner et al 2019. PubMed ID: 31785789, supplemental table 2). However, it is also reported in 0.012% of alleles in individuals of African descent in gnomAD, calling the significance of the de novo occurrence in Turner et al. into question. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.427G>A (p.G143R) alteration is located in exon 5 (coding exon 5) of the VPS16 gene. This alteration results from a G to A substitution at nucleotide position 427, causing the glycine (G) at amino acid position 143 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at